7/11/17

Segal Trials Announces Company Name Change to Segal Trials

After 19 years, Segal Trials proudly announces its corporate name change to Segal Trials effective, July 11, 2017.

Read More

7/6/17

Dr. Rishi Kakar of Segal Trials Partners with INC Research in the Launch of the Psychiatry Catalyst Site Network

Segal Trial’s, Dr. Rishi Kakar, is proud to be a part of INC Research’s elite group of sites that was selected to participate in the initial launch of the Psychiatry Catalyst Site Network. The Psychiatry Catalyst Site Network therapeutically-aligned network offers high-performing sites in psychiatry research the opportunity to conduct more trials and enhances high quality delivery for biopharmaceutical customers.

Read More

5/19/17

Segal Trials Launches New Employee Recognition Program

In honor of Clinical Trials Awareness Day, Segal Trials has implemented a new employee recognition program, the Diamond Club, to acknowledge their greatest asset – their staff.

Read More

3/28/17

Dr. Steven Chavoustie of Segal Trials Listed as an Author on Research Paper

Segal Trials’ Dr. Steven Chavoustie helped to author the research paper, “Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers,” recently published in the International Journal of Gynecology & Obstetrics, the official publication of the International Federation of Gynecology and Obstetrics (FIGO).

Read More

2/24/17

Curemark Announces Further Expansion of Clinical Sites For Its Phase 3 Clinical Trial for Children with Autism

Curemark, LLC announced today that the Blüm Study, a Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three new sites. These new sites are in addition to the 30 clinical sites already enrolling children across the United States….

Read More

9/20/16

Segal Trials Takes Essential Step to Reduce Duplicate Enrollment In Clinical Trials

Segal Trials has chosen Verified Clinical Trials (VCT), the global clinical trial database registry utilizing biometric fingerprint technology, to counter attempts at duplicate enrollment in clinical trial research and improve the safety of research volunteers and data quality…

Read More

5/11/16

Mental Health Organizations Work Together to Educate, Support and Encourage People to Take Action against an Illness that affects Millions of People Every Year

People are diagnosed with mental illness every day. Statistics alone would alarm anyone unfamiliar with the condition; a rare occurrence, as mental disorders affect one in four people…

Read More

1/8/16

Segal Trials Proudly Participates in Phase 3 Efficacy Trial of Long-acting Treatment Opioid Dependence

Segal Trials has three Principal Investigators currently participating in Braeburn Pharmaceuticals and Camurus’ Phase 3 efficacy Trial of Long-acting Treatment for Opioid …

Read More

1/8/16

Segal Trials Recognized as Top Fundraiser for Namiwalk Broward County

Segal Trials was recently recognized as the top fundraiser at the annual NAMIWalk Broward County during NAMI Broward County’s Holiday Party, Volunteer Recognition and Walk…

Read More

1/6/16

Dr.Rishi Kakar of Segal Trials Listed as an Author on Research Paper

Segal Trials’ Dr. Rishi Kakar helped to author the research paper, “A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from…

Read More